Talampanel, a New Antiepileptic Drug: Single- and Multiple-does Pharmacokinetics and Intial 1-Week Experience in patients with Chronic Intractable Epilepsy
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-01-01
著者
-
Patsalos Philip
Department Of Clinical And Experimental Epilepsy Institute Of Neurology Ucl
-
Patsalos Philip
Department Of Clinical And Expermental Epilepsy Institute Of Neurology
-
LANGAN Yvonne
Department of Clinical and Expermental Epilepsy, Institute of Neurology
-
LUCAS Richard
Eli Lilly & Company, Ltd., Lilly Research Centre
-
JEWELL Haley
Eli Lilly & Company, Ltd., Lilly Research Centre
-
TOUBLANC N.
Eli Lilly & Company, Ltd., Lilly Research Centre
-
SCHAEFER H.
Eli Lilly & Company, Ltd., Lilly Research Centre
-
SANDER Jasemire
Department of Clinical and Expermental Epilepsy, Institute of Neurology
-
Toublanc N.
Eli Lilly & Company Ltd. Lilly Research Centre
-
Jewell Haley
Eli Lilly & Company Ltd. Lilly Research Centre
-
Langan Yvonne
Department Of Clinical And Expermental Epilepsy Institute Of Neurology
-
Lucas Richard
Eli Lilly & Company Ltd. Lilly Research Centre
-
Sander Jasemire
Department Of Clinical And Expermental Epilepsy Institute Of Neurology
-
Schaefer H.
Eli Lilly & Company Ltd. Lilly Research Centre
関連論文
- The Importance of Drug Interactions in Epilepsy Therapy
- Talampanel, a New Antiepileptic Drug: Single- and Multiple-does Pharmacokinetics and Intial 1-Week Experience in patients with Chronic Intractable Epilepsy
- Synergism between Topiramate and Budipine in Refractory Status Epilepticus in the Rat